Wegovy · Semaglutide

Wegovy Coupons and Savings (2026 Guide)

Every active Wegovy discount for pill and pen, compared side by side. Updated monthly.

BBB AccreditedMedically reviewed byDr. Golsa Gholampour, MDLast updated2026-04-19
Quick answer

The cheapest Wegovy in 2026 is the once-daily pill at $149 per month for 1.5mg or 4mg starter doses through NovoCare Pharmacy. Commercially insured patients with Wegovy covered on their plan pay as low as $25 per month with the Savings Card. New cash-pay pen users pay $199 per month for the first 2 fills, then $349 per month for standard doses. Medicare, Medicaid, Tricare, VA, and DOD plans are excluded from the Savings Card by law, though Medicare Part D already covers Wegovy for cardiovascular event risk reduction in eligible patients.

Cheapest option today

The Wegovy pill is currently the cheapest Wegovy option at $149/mo

NovoCare Pharmacy sells the once-daily Wegovy tablet cash-pay at $149 per month for 1.5mg or 4mg starter doses. The 4mg dose is at $149 only through August 31, 2026, then reverts to $199 per month. Higher doses (9mg and 25mg) run $299 per month. This is the only FDA-approved semaglutide tablet for weight loss and is cheaper than any cash-pay pen option.

Section 1

Active Wegovy savings in 2026

Six programs across pill and pen formulations. Prices verified this month against Novo Nordisk's official pages.

Program
Wegovy Savings Card (covered)★ Best deal
Manufacturer program
Who qualifies
Commercial insurance, Wegovy covered on plan
Excludes Medicare, Medicaid, Tricare, VA, DOD.
Monthly cost
As low as $25/monthSubject to maximum savings of $100/month. Month defined as 1 box of 4 pens OR 1 bottle of 30 tablets.
Program
Wegovy Savings Card (not covered)
Manufacturer program
Who qualifies
Commercial insurance, Wegovy NOT covered
Excludes Medicare, Medicaid, Tricare, VA, DOD.
Monthly cost
Discount available, varies by planExact out-of-pocket varies by formulation, pharmacy, and program caps. Historically up to $650/month savings. Most uncovered commercial patients use NovoCare Self-Pay instead.
Program
NovoCare Pharmacy Self-Pay (Wegovy Pill)
Direct-from-manufacturer (cash pay)
Who qualifies
No insurance, or insured but Wegovy not covered; prescription required
Monthly cost
$149 to $299 depending on dosePromotional pricing on starter doses through Aug 31, 2026.
Program
NovoCare Pharmacy Self-Pay (Wegovy Pen — New Patient Intro)
Direct-from-manufacturer (cash pay)
Who qualifies
New to Wegovy Savings Offer or NovoCare Pharmacy, prescription required
Monthly cost
$199/month for first 2 fillsFor 0.25mg and 0.5mg starter doses only. Expires after 2 fills or June 30, 2026, whichever comes first.
Program
NovoCare Pharmacy Self-Pay (Wegovy Pen — Standard Doses)
Direct-from-manufacturer (cash pay)
Who qualifies
Self-pay patients past the new-patient intro period
Monthly cost
$349/monthApplies to all standard pen doses: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg.
Program
NovoCare Pharmacy Self-Pay (Wegovy HD 7.2mg)
Direct-from-manufacturer (cash pay)
Who qualifies
Self-pay patients using the high-dose 7.2mg pen
Monthly cost
$399/monthFor the 7.2mg Wegovy HD dose only.
List price without any program: $1349.02 per 28-day supply (pen). All savings reference this baseline.
Section 2

Which Wegovy savings program fits you?

Start with your insurance status. Each branch ends at the lowest legal path available to you today.

1
Branch 1
Commercial insurance, Wegovy covered
Employer, ACA marketplace, or private plan with Wegovy on formulary
2
Branch 2
Commercial insurance, Wegovy not covered
Plan excludes GLP-1 weight-loss medications
APrefer Wegovy pill (cheaper)

Consider requesting a formulary exception first. Appeal process may unlock full coverage.

3
Branch 3
Medicare / Medicaid / Tricare / VA (current)
Federal or state-funded plans, before April 2026 Medicare rollout

Savings Card is excluded for federal plans. Medicare coverage for Wegovy may begin as early as April 2026 (for obesity or cardiovascular indications). Medicaid coverage for obesity varies: 13 states cover GLP-1s as of Jan 2026. Medicare Part D already covers Wegovy when prescribed for cardiovascular event risk reduction in eligible patients with established heart disease.

4
Branch 4
Uninsured / Cash pay
No current prescription drug coverage
Section 3

A note on compounded semaglutide

⚠ Legal status changed

FDA declared the semaglutide shortage resolved in early 2025. As of 2025-2026, pharmacies are no longer permitted to regularly compound semaglutide injections. Narrow exceptions exist for documented patient-specific medical needs (e.g., allergy to inactive ingredients in commercial Wegovy/Ozempic).

Beware of counterfeit semaglutide or providers claiming to offer compounded semaglutide without documented patient-specific medical need. Counterfeit semaglutide is a known safety risk.

Use NovoCare Pharmacy Self-Pay (pill $149+, pen $199-$349) as the current legitimate cash-pay path. Compounded semaglutide is no longer a reliable cost-saving option.

Section 4

Frequently asked questions

Every question patients ask most often about Wegovy coupons and savings.

No. Federal insurance programs (Medicare, Medicaid, Tricare, VA, DOD) are explicitly excluded from the Wegovy Savings Card by law. This is true of nearly all manufacturer copay cards. Medicare Part D already covers Wegovy when prescribed for cardiovascular event risk reduction in eligible patients with established heart disease and either obesity or overweight (FDA-approved indication as of March 2024). For weight loss alone, Medicare coverage may begin as early as April 2026 under a new federal pricing framework, with copays capped at approximately $50/month for eligible enrollees.
Find your cheapest option

Not sure which Wegovy option is right for you?

Take our 90-second quiz. We match you to the lowest-cost Wegovy path based on your insurance, preference for pill or pen, and medical history.

Methodology & medical review

Pricing verified against Novo Nordisk's official wegovy.com and novocare.com pages, cross-referenced with GoodRx, Weight Watchers, Walgreens, and SingleCare. We do not accept payment for inclusion in any comparison. Medical content reviewed by Dr. Golsa Gholampour, MD, board-certified in obesity medicine. Quarterly re-verification scheduled.

Medically reviewed by Dr. Golsa Gholampour, MD
Reviewed 2026-04-19. Pricing last verified 2026-04-19.